In that study, the most abundant cytokine-receptor pair interaction between TAMs and tumor cells was predicted for IL1B and its decoy receptor IL1R2, suggesting inhibition of IL1B-mediated proinflammatory signaling by tumor cells. Here, IL1B is linked to neoplasm.